tiprankstipranks
Oruka Therapeutics, Inc. (ORKA)
NASDAQ:ORKA
US Market
ORKA
Oruka Therapeutics
RESEARCH TOOLSreports
Want to see ORKA full AI Analyst Report?

Oruka Therapeutics (ORKA) Stock News & Sentiment

814 Followers
Oruka: Strong ORKA-001 Clinical Profile and Pipeline Momentum Support Reiterated Buy Rating and Unchanged $120 Price Target
Premium
Ratings
Oruka: Strong ORKA-001 Clinical Profile and Pipeline Momentum Support Reiterated Buy Rating and Unchanged $120 Price Target
11d ago
ORKA
Julian Harrison Reiterates Buy on Oruka Therapeutics, Maintains $151 Price Target on Strong Clinical Profile and Cash Position
Premium
Ratings
Julian Harrison Reiterates Buy on Oruka Therapeutics, Maintains $151 Price Target on Strong Clinical Profile and Cash Position
15d ago
ORKA
Oruka Initiated With Buy on Best-in-Class ORKA-001 Psoriasis Data, Strong Cash Position, and Multi-Billion-Dollar Upside Potential
Premium
Ratings
Oruka Initiated With Buy on Best-in-Class ORKA-001 Psoriasis Data, Strong Cash Position, and Multi-Billion-Dollar Upside Potential
15d ago
ORKA
Oruka Therapeutics Completes Public Equity Offering Under Shelf
Premium
Company Announcements
Oruka Therapeutics Completes Public Equity Offering Under Shelf
28d ago
8K
ORKA
Morning News Wrap-Up, 4/27/26: Today’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up, 4/27/26: Today’s Biggest Stock Market Stories!
1M ago
AMD
DIA
This Is Why Oruka Therapeutics Stock (ORKA) Soared Today
Premium
Market News
This Is Why Oruka Therapeutics Stock (ORKA) Soared Today
1M ago
ORKA
Oruka Therapeutics Reports Strong Phase 2 Psoriasis Results
Premium
Company Announcements
Oruka Therapeutics Reports Strong Phase 2 Psoriasis Results
1M ago
8K
ORKA
More ORKA News >

ORKA News on the Web

Why Oruka Therapeutics Stock Is Sliding Hard
TipRanks News
Neutral
Analysts Have Conflicting Sentiments on These Healthcare Companies: Alcon (ALC) and Oruka Therapeutics (ORKA)
TipRanks News
Bullish
Oruka: Strong ORKA-001 Clinical Profile and Pipeline Momentum Support Reiterated Buy Rating and Unchanged $120 Price Target
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), GH Research (GHRS) and Doximity (DOCS)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Assertio Therapeutics (ASRT), Aytu BioScience (AYTU) and Oruka Therapeutics (ORKA)
TipRanks News
Bullish
Piper Sandler Reaffirms Their Buy Rating on Oruka Therapeutics (ORKA)
TipRanks News
Bullish
Julian Harrison Reiterates Buy on Oruka Therapeutics, Maintains $151 Price Target on Strong Clinical Profile and Cash Position
TipRanks News
Bullish
Barclays Remains a Buy on Oruka Therapeutics (ORKA)
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
ORKA
Sector Average
Media Buzz
This Week2 articles
Weekly Average12 articles
News Sentiment
This Week100%
Sector Average79%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ORKA’s Media Buzz Sentiment?
2 articles about ORKA were published this week. In an average week, 12 articles are published.
    What is ORKA’s weekly average amount of articles?
    In an average week, 12 articles about ORKA are published.
      What is ORKA’s News Sentiment?
      100% of articles about ORKA were positive this week, compared to its sector average of 79%.
        Healthcare Stocks that are Trending in the News
        AKTXAkari Therapeutics
        IMMXImmix Biopharma
        SYSo-Young International
        ADOAnteoTech Ltd
        FSPKFFisher & Paykel Healthcare Corporation Limited
        Showing the stocks with the most bullish news sentiment over the past week